Dr.john P. Chaney L.l.c. in Central City, SD - Clinic/Center

Dr.john P. Chaney L.l.c. is a primary clinic (Clinic/center) in Central City, South Dakota. The current practice location for Dr.john P. Chaney L.l.c. is 136a Us Highway 14a, Central City, South Dakota. For appointments, you can reach them via phone at (605) 584-1500. The mailing address for Dr.john P. Chaney L.l.c. is 136a Us Highway 14a, Central City, South Dakota and phone number is (605) 584-1500.

Dr.john P. Chaney L.l.c. is licensed to practice in South Dakota (license number 834) and its NPI number is 1568794154. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (605) 584-1500.

Contact Information

	Dr.john P. Chaney L.l.c.
	136a Us Highway 14a Central City SD 57754-2054
	(605) 584-1500
	(605) 722-1188

Primary Care Clinic Profile

Full Name	Dr.john P. Chaney L.l.c.
Speciality	Clinic/center
Location	136a Us Highway 14a, Central City, South Dakota
Authorized Official Name and Position	John P. Chaney (PRESIDENT AND OPERATING MANAGER)
Authorized Official Contact	6055841500
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr.john P. Chaney L.l.c. 136a Us Highway 14a Central City SD 57754-2054 Ph: (605) 584-1500	Dr.john P. Chaney L.l.c. 136a Us Highway 14a Central City SD 57754-2054 Ph: (605) 584-1500

NPI Details:

NPI Number	1568794154
Provider Enumeration Date	02/05/2010
Last Update Date	11/17/2010

Medical Identifiers

Medical identifiers for Dr.john P. Chaney L.l.c. such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1568794154	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
261Q00000X	Clinic/center	834 (South Dakota)	Primary

News Archive

Researchers uncover 13 novel genetic loci linked with onset of menopause

An international team of researchers from the Boston University Schools of Public Health and Medicine and other institutions has uncovered 13 genetic loci, linked to immune function and DNA repair, that are factors in the age of onset of menopause.

European Commission and US FDA approve intravenous formulation of temozolomide

Schering-Plough Corporation (NYSE:SGP) today announced that the European Commission and the US FDA both approved the intravenous (IV) formulation of temozolomide as an alternative to the already approved oral form of the drug.

Study: Cholesterol uptake is decreased in GM3S-deficient cells

Approximately 1 in every 4 deaths in the United States is caused by heart disease, according to the Centers for Disease Control and Prevention.

Mayo Clinic develops new screening procedure for Lynch syndrome detection

Mayo Clinic has developed a screening procedure that could dramatically increase testing for Lynch syndrome, a hereditary genetic disorder that raises cancer risk, particularly for colorectal cancer.

Dr.john P. Chaney L.l.c. - Primary Care in Central City, SD